Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis
Condition: Type2diabetes Intervention: Sponsors: Diabetes Foundation, India; National Diabetes Obesity and Cholesterol Foundation Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cholesterol | Diabetes | Eating Disorders & Weight Management | Endocrinology | India Health | Liver | Obesity | Research | Urology & Nephrology